Alsvid Pharma SRL
Alsvid Pharma reported total assets of 261,182 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jul 2026).
The score of Alsvid Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +236 % Total assets +123 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Alsvid Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
Alsvid Pharma's financial analysis
- Solvency18.9%sector median: 36.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Alsvid Pharma
Alsvid Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0797.937.044
- VAT number
- BE0797937044
- Peppol
- Registered · 0208:0797937044 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Feb 2023
- Registered office
- 8690 Alveringem
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Manufacture of other food products n.e.c. (NACE 10890)
Alsvid Pharma (SRL) has been based in Alveringem since 2023, active in: manufacture of other food products n.e.c.. For 2025, it reports a net profit of 22,127 € and equity of 49,299 €; its revenue is not published. Its solvency stands at 18.9%, below the median of its sector (36.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Alsvid Pharma
Companies in the same business, of comparable size and area, outside its group.
- Brussels Medical Center Manufacture of pharmaceutical preparations Oostkamp · balance sheet 272,306 €
- Cerdak Manufacture of pharmaceutical preparations Lanaken · balance sheet 103,436 €
- Primrose Laboratories Manufacture of other chemical products n.e.c. Torhout · balance sheet €1.90m
- RPO NucleoGenesis Manufacture of basic pharmaceutical products Ghent · balance sheet 107,514 €
- SmileLab Manufacture of medical and dental instruments and supplies Soignies · balance sheet 515,809 €
- Estrella Clinical Research Manufacture of basic pharmaceutical products Herentals · balance sheet 41,482 €
- Chrometra Scientific Manufacture of other chemical products n.e.c. Kortenaken · balance sheet 72,995 €
- Laboratoires Biogam Manufacture of pharmaceutical preparations Forest · balance sheet €2.68m
Frequently asked questions about Alsvid Pharma
What is the revenue of Alsvid Pharma?
Alsvid Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Alsvid Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0797937044 for Alsvid Pharma, if the company is VAT-registered. Its company number (CBE) is 0797.937.044.
Where is the registered office of Alsvid Pharma?
According to the CBE register, the registered office of Alsvid Pharma is in 8690 Alveringem.
What is the equity of Alsvid Pharma?
At the close of the 2025 financial year, the equity of Alsvid Pharma amounts to 49,299 €, a solvency of 18.9% of total assets.
Who manages Alsvid Pharma?
The register lists 2 active mandates at Alsvid Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Alsvid Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →